{"url":"https://lda.gov/api/v1/filings/3d372a1c-6301-445e-a354-51db7e5ac808/","filing_uuid":"3d372a1c-6301-445e-a354-51db7e5ac808","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3d372a1c-6301-445e-a354-51db7e5ac808/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ryan M. Bernstein, Sr. Vice President and Director","dt_posted":"2026-07-14T13:12:14-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"888 16th Street, N.W.; Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":24486,"url":"https://lda.gov/api/v1/registrants/24486/","house_registrant_id":33788,"name":"MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)","description":"​Public Affairs Government Relations Services","address_1":"888 16th Street, N.W.; Suite 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RYAN M. BERNSTEIN","contact_telephone":"+1 202-857-2909","dt_updated":"2026-07-29T10:26:26.735165-04:00"},"client":{"id":68217,"url":"https://lda.gov/api/v1/clients/68217/","client_id":68217,"name":"OSTEAL THERAPEUTICS, INC.","general_description":"Biopharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-06-16"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"General federal government relations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106724,"prefix":null,"prefix_display":null,"first_name":"CLAYTON","nickname":null,"middle_name":"T.","last_name":"COX","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":79570,"prefix":null,"prefix_display":null,"first_name":"SCOTT","nickname":null,"middle_name":null,"last_name":"BINKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148857,"prefix":null,"prefix_display":null,"first_name":"MIMI","nickname":null,"middle_name":null,"last_name":"BAIR","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}